ClinicalTrials.gg
RecruitingNCT06072287LTCUpdated Oct 12, 2023

The Living With a Long-Term Condition Study

An observational study in Asthma, Atrial Fibrillation and Cancer, sponsored by King's College London. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-10-12.

Sponsored by King's College London · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2023, 2 years 10 months ago, but the record still lists the study as recruiting.
  • Started Jun 2023; still recruiting 3 years 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
600
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 558 studies in Asthma with a site in United Kingdom — 52 open to participants now, 71 under way, 11 of them phase 3. Asthma · United Kingdom.

Planned enrollment
31st of 131
600 · median 149
Started
2023
with 24 others
Observational
131 of 558
24 open now
Primary completion
2023-12
later than 1 of 70 live
Registered
492nd of 558
by date

Among the 558 studies in Asthma with a site in United Kingdom, this one is the 31st largest by planned enrollment of the 131 observational ones that give a count, is one of 25 that started in 2023, is one of 131 observational ones, reaches primary completion later than 1 of the 70 other live ones, and was the 492nd registered.

Asthma

4,850 studies on the registry are indexed under Asthma; 604 are open to participants now.

Browse Asthma studies →

Open to participants now

52 of the 558 studies in Asthma with a site in United Kingdom are open now. Recruiting first, the newest first:

47 more — sign in →

All 52 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 416 Asthma studies recruiting now, 141 (34%) set no upper age limit and 204 (49%) stop at 75 or younger; 146 take children under 18; 105 take healthy volunteers.

This study: 18 Years and older · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 558 studies in Asthma with a site in United Kingdom, or all of them as a file.
02

Study summary

Psychological distress (anxiety and depression) is common in and experienced differently by people living with long-term health conditions (LTCs). Being able to measure whether psychological distress is related to living with a LTC would allow researchers and clinicians to provide interventions specifically tailored to the challenges of living with a LTC and therefore provide the most appropriate support for these patients. Such a measure would also be useful in research to identify the presence of illness-related distress in different patient groups. This project will therefore create a new measure of illness-related distress that has applications for both research and clinical practice. This will involve the psychometric validation of the new illness-related distress measure to test how valid and reliable the measure is.

The aim of the project is to provide initial validation of the Illness Related Distress Scale in a community sample, recruited through online platforms. The objective of the study is to gather initial validity and reliability data for the scale.

Read the detailed description

Background: see brief summary

Project information:

This study will be conducted online with participants from the UK. A series of standardised questionnaires will be used alongside the new questionnaire.

Participants will be those who self-select to complete our survey by responding to advertisements. The invitation will include a link to the Qualtrics survey which includes the Participant Information Sheet, Eligibility Screening, Consent Form and Baseline Questionnaire.

After completing eligibility screening and consent, participants will complete the baseline questionnaire which will include brief demographics (highest education level, long-term condition diagnoses, ethnicity age and gender), the new measure we are testing (the Illness Related Distress Scale), as well as the Patient Health Questionnaire (PHQ-8), Generalised Anxiety Disorder Scale (GAD-7), the Work and Social Adjustment Scale (WSAS). The baseline questionnaire will only include the Inflammatory Bowel Disease Distress Scale (IBD-DS) and Diabetes Distress Scale (DDS) if participants indicate that they have a diagnosis of the relevant condition.

At 1 week follow-up, participants will be sent a Qualtrics link to complete our 1-week follow-up questionnaire which will include the new Illness-Related Distress Scale only.

Participants:

We are aiming to recruit 600-700 participants for the study.

03

Conditions studied

  • Asthma
  • Atrial Fibrillation
  • Cancer
  • Cerebrovascular Disorders
  • Stroke
  • CKD
  • Copd
  • Fibromyalgia
  • Pain
  • Heart Diseases
  • Heart Disease Chronic
  • Dementia
  • Diabetes
  • Epilepsy
  • Heart Failure
  • High Blood Pressure
  • Hypertension
  • Hiv
  • AIDS
  • IBD
  • IBS
  • Liver Diseases
  • Long COVID
  • Lupus Erythematosus
  • Multiple Sclerosis
  • Obesity
  • Osteoarthritis
  • Arthritis
  • Rheumatoid Arthritis
  • Osteoporosis
  • Parkinson Disease
  • Sickle Cell Disease
  • Hepatitis
  • Endometriosis
  • PCOS
  • Neurological Disorder
  • POTS - Postural Orthostatic Tachycardia Syndrome
  • MND (Motor Neurone DIsease)
  • Cystic Fibrosis
  • Migraine
  • Spondylitis
  • Celiac Disease
  • Hidradenitis Suppurativa
  • Eczema
  • ME/CFS

Keywords

  • mental health
  • depression
  • anxiety
  • chronic illness
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Adults in the UK with a diagnosis of a Long-Term Condition or chronic illness.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Over the age of 18
  • Self-reported diagnosis of a Long-Term Condition
  • UK resident
  • Possession of an email address to enable all study procedures
  • Sufficient command of written and spoken English to understand study procedures

Exclusion criteria

Exclusion Criteria:

  • Under the age of 18
  • Not living in the UK
  • No self-reported diagnosis of an LTC
  • Inability to complete questionnaires in English
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
600 participants (estimated)
Patient registry
No

Groups and cohorts

  • Participants

    Participants will answer two short questionnaires, 1 week apart.

    Diagnostic Test: Living with LTC Questionnaire

Interventions

  • Diagnostic testLiving with LTC Questionnaire

    A questionnaire that will ask about demographic information, mental wellbeing and distress related to chronic illness.

06

What researchers measure

Primary outcomes

  1. Illness-related distress

    31 item questionnaire developed by the research team designed to assess illness-related distresss.

    Time frame: Week 0 and Week 1

Secondary outcomes

  1. Depression

    Eight-item Patient Health Questionnaire - 8 (PHQ-8) Minimum=0, maximum=24, with higher scores indicating greater depression.

    Time frame: Week 0

  2. Anxiety

    Seven-item Generalised Anxiety Disorder Scale (GAD-7). Minimum=0, maximum=21, with higher scores indicating greater anxiety.

    Time frame: Week 0

  3. Functional impairment

    Five-item Work and Social Adjustment Scale (WSAS). Minimum=0, maximum=50, with higher scores indicating greater functional impairment.

    Time frame: Week 0

  4. Diabetes Related Distress Scale

    Diabetes Related Distress Scale (DDS-17), a 17 item self-report diabetes related distress questionnaire. Minimum=17, maximum=102, with higher scores indicating greater distress.

    Time frame: Week 0

  5. IBD Distress Scale

    IBD Distress Scale, a 28 item self-report IBD related distress questionnaire. Minimum=29, maximum=145, with higher scores indicating greater distress.

    Time frame: Week 0

  6. Cognitive and Behavioural Responses to Symptoms

    Cognitive Behavioural Responses to Symptoms Questionnaire, 40 item self-report questionnaire consisting of seven subscales with items scored on a 5 point scale. Higher scores correspond with stronger presence of the specific cognitive/behavioural response. The seven subscales refer to 1) fear avoidance, 2) catastrophising, 3) damage beliefs, 4) embarassment avoidance 5) symptom focussing 6) all-or-nothing behaviour and 7) avoidance/resting behaviour.

    Time frame: Week 0

07

Study locations

1 of 1 sites recruiting
  • King's College London
    London, SE1 9RT, United Kingdom
    Recruiting
    • Natasha Seaton, MSc · Contactnatasha.seaton@kcl.ac.uk · 0207 188 1189
    • · ContactLTC-Study@kcl.ac.uk
    • Annie Jones, PhD · Sub investigator
    • Emma Jenkinson, MSc · Sub investigator
    • Rona Moss-Morris, PhD · Principal investigator
    • Joanna Hudson, PhD · Sub investigator
    • Natasha Seaton, MSc · Sub investigator
08

References and documents

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2023 (actual). Primary completion is estimated for Dec 2023, 6 months after the start.

Of 366 non-industry observational studies under Asthma, half reached primary completion within 38 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 97. This study's planned 6 months is below that.

Counting every sponsor, half of 456 studies reached it within 36 months; a quarter within 18 and three quarters within 82.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 2, 2023
First posted
Oct 10, 2023
StartActual
Jun 28, 2023
Primary completionEst.
Dec 31, 2023
CompletionEst.
Jan 10, 2024
Last update
Oct 12, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 12, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06072287
Responsible party
Sponsor
First posted
Oct 10, 2023
Start date
Jun 28, 2023
Primary completion
Dec 31, 2023 (estimated)
Completion
Jan 10, 2024 (estimated)
Last update
Oct 12, 2023

Study contacts

Natasha Seaton, MSc
Contact
LTC-study@kcl.ac.uk
0207 188 1189
Natasha Seaton, MSc
Contact
natasha.seaton@kcl.ac.uk
0207 188 1189
Rona Moss-Morris, PhD
principal investigator · King's College London
Annie Jones, PhD
study director · King's College London
Emma Jenkinson, MSc
study director · King's College London
Natasha Seaton, MSc
study director · King's College London

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion